{"id":"NCT01725308","sponsor":"Astellas Pharma Inc","briefTitle":"A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes","officialTitle":"Phase II/III Study of FK949E: Placebo-controlled, Double-blind, Parallel-group Comparative Study and Open-label, Non-controlled Extension Study in Bipolar Disorder Patients With Major Depressive Episodes","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-02-07","primaryCompletion":"2015-08-01","completion":"2016-07-11","firstPosted":"2012-11-12","resultsPosted":"2017-02-08","lastUpdate":"2024-11-15"},"enrollment":431,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder"],"interventions":[{"type":"DRUG","name":"FK949E","otherNames":["quetiapine"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"FK949E 150 mg","type":"EXPERIMENTAL"},{"label":"FK949E 300 mg","type":"EXPERIMENTAL"},{"label":"Placebo / FK949E","type":"EXPERIMENTAL"},{"label":"FK949E 150 mg / FK949E","type":"EXPERIMENTAL"},{"label":"FK949E 300 mg / FK949E","type":"EXPERIMENTAL"}],"summary":"In period I, the treatment effect of FK949E was compared with that of placebo in a blind manner in bipolar disorder patients with major depressive episodes. In period II, the long-term safety and efficacy of FK949E was evaluated.","primaryOutcome":{"measure":"Change From Baseline to End of Treatment Period I in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score","timeFrame":"Baseline and Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-10.1,"sd":10.9},{"arm":"FK949E 150 mg","deltaMin":-14.4,"sd":11.4},{"arm":"FK949E 300 mg","deltaMin":-12.6,"sd":11.4}],"pValues":[{"comp":"OG000 vs OG002","p":"0.034"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":22},"locations":{"siteCount":98,"countries":["Japan"]},"refs":{"pmids":["32792252","32518042","31242884"],"seeAlso":["https://www.astellasclinicalstudyresults.com/study.aspx?ID=221"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":177},"commonTop":["Somnolence","Nasopharyngitis","Thirst","Constipation","Akathisia"]}}